| Numurs | Nosaukums |
|---|---|
| NVD11R.1.4.2 | Ondansetron Baxter 2 mg/ml šķīdums injekcijām |
| NVD11R.14.2.2 | HEXVIX 85mg plv.+ šķīd. |
| NVD11R.1.4.3 | EMETRON tabl.8mg N10 |
| NVD11R.14.3.2 | SODIUM CHLOR.0,9% inj.10ml N20 |
| NVD11R.14.3.3 | Sodium chloride Kabi 0,9% šķīdinātājs parenterālai lietošanai |
| NVD11R.14.3.4 | Aqua destillata Kalceks amp.10ml N10 |
| NVD11R.14.3.5 | Aqua destillata Kabi amp.20ml N20 |
| NVD11R.14.3.6 | ŪDENS INJEKCIJĀM 250ML N20 |
| NVD11R.14.3.7 | ŪDENS INJEKCIJĀM 500ML N20 |
| NVD11R.14.3.8 | ŪDENS INJEKCIJĀM 1000ml N10 |
| NVD11R.14.4.1 | UROGRAFIN 76% AMP.20ML N10 |
| NVD11R.14.4.11 | Ultravist-370 flac.100ml N10 |
| NVD11R.14.4.12 | Ultravist-370 flac.200ml N10 |
| NVD11R.14.4.13 | Ultravist 370 500ml |
| NVD11R.14.4.14 | Ultravist-300 flac.50ml N10 |
| NVD11R.14.4.15 | Ultravist-300 flac.100ml N10 |
| NVD11R.14.4.16 | Ultravist-300 flac.200ml N10 |
| NVD11R.14.4.17 | Ultravist-300 flac.500ml N8 |
| NVD11R.14.4.18 | VISIPAQUE 550(270)mg/ml50mlN10 |
| NVD11R.14.4.19 | VISIPAQUE 55 g/100 ml |